General Information of the Compound
Compound ID |
CP0049010
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
4 -chlorodiazepam
Show/Hide
|
||||||||||||||||||
Synonyms |
14439-61-3
2H-1,4-Benzodiazepin-2-one, 7-chloro-5-(4-chlorophenyl)-1,3-dihydro-1-methyl-
2QW0IK1742
4 inverted exclamation marka-Chlorodiazepam
4'-Chlorodiazepam
4-Chlorodiazepam
7-Chloro-1,3-dihydro-1-methyl-5-(p-chlorophenyl)-2H-1,4-benzodiazepin-2-one
7-Chloro-5-(4-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one
7-chloro-5-(4-chlorophenyl)-1-methyl-3H-1,4-benzodiazepin-2-one
BRN 0685202
Benzodiazepine derivative 1
CHEMBL286346
HSDB 6958
MLS000069627
NB-3040
PMID27607364-Compound-3
RO5-4864
Ro 5-4864
Ro-05-4864
Ro-5-4864
SMR000058205
UNII-2QW0IK1742
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C16H12Cl2N2O
|
||||||||||||||||||
Molecular Weight |
319.191
|
||||||||||||||||||
Canonical SMILES |
CN1c2ccc(Cl)cc2C(=NCC1=O)c1ccc(Cl)cc1
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C16H12Cl2N2O/c1-20-14-7-6-12(18)8-13(14)16(19-9-15(20)21)10-2-4-11(17)5-3-10/h2-8H,9H2,1H3
Show/Hide
|
||||||||||||||||||
InChIKey |
PUMYFTJOWAJIKF-UHFFFAOYSA-N
|
||||||||||||||||||
CAS |
14439-61-3
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( Ro 5-4864 )
Drug Name | Ro 5-4864 | ||
---|---|---|---|
Indication | |||
Target(s) |
Translocator protein (TSPO)
Binder
|